vs
Criteo S.A.(CRTO)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Criteo S.A.的1.5倍($702.9M vs $482.7M),Healthpeak Properties净利率更高(51.6% vs 4.4%,领先47.2%),Criteo S.A.同比增速更快(2.4% vs -6.6%),过去两年Criteo S.A.的营收复合增速更高(1.4% vs 0.5%)
Criteo S.A.是一家总部位于法国巴黎的广告服务商,专注于为客户提供在线展示广告服务,帮助品牌与媒体触达目标受众,是全球互联网广告领域的知名企业,深耕效果营销领域多年,服务众多跨境与本土客户。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
CRTO vs DOC — 直观对比
营收规模更大
DOC
是对方的1.5倍
$482.7M
营收增速更快
CRTO
高出9.1%
-6.6%
净利率更高
DOC
高出47.2%
4.4%
两年增速更快
CRTO
近两年复合增速
0.5%
损益表 — Q2 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $482.7M | $702.9M |
| 净利润 | $21.3M | $363.0M |
| 毛利率 | 53.6% | — |
| 营业利润率 | 6.3% | 0.7% |
| 净利率 | 4.4% | 51.6% |
| 营收同比 | 2.4% | -6.6% |
| 净利润同比 | -21.3% | 28.3% |
| 每股收益(稀释后) | $0.39 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CRTO
DOC
| Q1 26 | — | $702.9M | ||
| Q4 25 | — | $719.4M | ||
| Q3 25 | — | $705.9M | ||
| Q2 25 | $482.7M | $694.3M | ||
| Q1 25 | $451.4M | $702.9M | ||
| Q4 24 | $553.0M | $698.0M | ||
| Q3 24 | $458.9M | $700.4M | ||
| Q2 24 | $471.3M | $695.5M |
净利润
CRTO
DOC
| Q1 26 | — | $363.0M | ||
| Q4 25 | — | $114.0M | ||
| Q3 25 | — | $-117.1M | ||
| Q2 25 | $21.3M | $31.7M | ||
| Q1 25 | $37.9M | $42.8M | ||
| Q4 24 | $71.1M | $4.5M | ||
| Q3 24 | $6.2M | $85.9M | ||
| Q2 24 | $27.0M | $146.0M |
毛利率
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | 53.6% | 60.2% | ||
| Q1 25 | 52.5% | 61.1% | ||
| Q4 24 | 54.4% | 60.3% | ||
| Q3 24 | 50.5% | 60.0% | ||
| Q2 24 | 49.4% | 60.6% |
营业利润率
CRTO
DOC
| Q1 26 | — | 0.7% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 9.2% | ||
| Q2 25 | 6.3% | 5.7% | ||
| Q1 25 | 10.7% | 7.7% | ||
| Q4 24 | 17.1% | -2.2% | ||
| Q3 24 | 2.1% | 14.1% | ||
| Q2 24 | 7.8% | 22.3% |
净利率
CRTO
DOC
| Q1 26 | — | 51.6% | ||
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | -16.6% | ||
| Q2 25 | 4.4% | 4.6% | ||
| Q1 25 | 8.4% | 6.1% | ||
| Q4 24 | 12.9% | 0.7% | ||
| Q3 24 | 1.4% | 12.3% | ||
| Q2 24 | 5.7% | 21.0% |
每股收益(稀释后)
CRTO
DOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $-0.17 | ||
| Q2 25 | $0.39 | $0.05 | ||
| Q1 25 | $0.66 | $0.06 | ||
| Q4 24 | $1.21 | $0.02 | ||
| Q3 24 | $0.11 | $0.12 | ||
| Q2 24 | $0.46 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $223.6M | $-1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $7.8B |
| 总资产 | $2.1B | $21.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CRTO
DOC
| Q1 26 | — | $-1.2B | ||
| Q4 25 | — | $467.5M | ||
| Q3 25 | — | $91.0M | ||
| Q2 25 | $223.6M | $89.4M | ||
| Q1 25 | $313.2M | $70.6M | ||
| Q4 24 | $316.9M | $119.8M | ||
| Q3 24 | $231.8M | $180.4M | ||
| Q2 24 | $233.2M | $106.9M |
总债务
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益
CRTO
DOC
| Q1 26 | — | $7.8B | ||
| Q4 25 | — | $7.5B | ||
| Q3 25 | — | $7.6B | ||
| Q2 25 | $1.1B | $7.9B | ||
| Q1 25 | $1.1B | $8.2B | ||
| Q4 24 | $1.0B | $8.4B | ||
| Q3 24 | $1.1B | $8.6B | ||
| Q2 24 | $1.0B | $8.8B |
总资产
CRTO
DOC
| Q1 26 | — | $21.6B | ||
| Q4 25 | — | $20.3B | ||
| Q3 25 | — | $19.6B | ||
| Q2 25 | $2.1B | $19.8B | ||
| Q1 25 | $2.1B | $19.8B | ||
| Q4 24 | $2.3B | $19.9B | ||
| Q3 24 | $2.2B | $20.0B | ||
| Q2 24 | $2.2B | $20.2B |
负债/权益比
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.4M | — |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | — |
| 自由现金流率自由现金流/营收 | -7.6% | — |
| 资本支出强度资本支出/营收 | 7.3% | 3.4% |
| 现金转化率经营现金流/净利润 | -0.07× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $315.0M | ||
| Q2 25 | $-1.4M | $363.5M | ||
| Q1 25 | $62.3M | $279.4M | ||
| Q4 24 | $169.5M | $1.1B | ||
| Q3 24 | $57.5M | $318.2M | ||
| Q2 24 | $17.2M | $316.2M |
自由现金流
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | $357.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | $-36.6M | — | ||
| Q1 25 | $45.3M | — | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | $-4.0M | — |
自由现金流率
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | -7.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.9% | — |
资本支出强度
CRTO
DOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | — | 124.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | — | 105.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.5% | — |
现金转化率
CRTO
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | 10.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.07× | 11.48× | ||
| Q1 25 | 1.64× | 6.52× | ||
| Q4 24 | 2.38× | 235.43× | ||
| Q3 24 | 9.21× | 3.71× | ||
| Q2 24 | 0.64× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRTO
| Commerce Growth | $393.9M | 82% |
| Retail Media | $60.9M | 13% |
| Other | $27.9M | 6% |
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |